Outcome of Overweight AF Patients Following Ablation With a Potential Weight Loss Medication ( GOAL-AF ) (opens ClinicalTrials.gov)
- Sponsor
- University Hospital Birmingham
- Enrolment
- 29
- Started
- 2022-04-17
- Last update
- 2025-07-28
Conditions: Atrial Fibrillation, Recurrence, Overweight and Obesity, Liraglutide
Interventions: Liraglutide plus upstream risk factors modification advice and consultation